Additive Complex Ayurvedic Treatment in Patients with Fibromyalgia Syndrome Compared to Conventional Standard Care Alone: A Nonrandomized Controlled Clinical Pilot Study (KAFA Trial)

Table 1

Baseline characteristics.

Characteristics	Integrative medicine group	Rheumatology group	𝑃 value
Male/female, no.	0/21	0/11	n.a.
Age, years	54.4±9.3	47.8±13.6	0.11
Body mass index, kg/m^2	26.8±4.5	28.0±4.4	0.46
SBP, mmHg	128±14	129±10	0.77
DBP, mmHg	75.3±9.3	78.1±8.0	0.46
FIQ score	46.9±12.6	51.0±12.2	0.38
Pain score (NRS)	6.0±1.9	6.7±2.5	0.34
Quality of sleep	4.0±1.9	3.5±3.1	0.59
STAI state score	52.4±6.0	50.7±11.2	0.65
STAI trait score	45.9±11.5	46.8±11.4	0.83
HADS anxiety	8.8±3.6	9.0±3.8	0.89
HADS depression	7.4±3.4	7.4±3.6	0.96
SES sensory pain perception	20.9±5.8	20.7±6.0	0.95
SES affective pain perception	31.7±8.4	34.6±9.2	0.38

Values are mean ± SD if not indicated otherwise. SBP: systolic blood pressure; DBP: diastolic blood pressure.
STAI: state and trait anxiety questionnaire, FIQ: fibromyalgia impact questionnaire; HADS: hospital anxiety and depression scale; NRS: numeric rating scale 0–10; SES: pain perception scale.